NDAORALTABLET, EXTENDED RELEASE
Approved
Aug 1996
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
1
Data completeness
4/8 — Partial
CLARITIN-D 24 HOUR (loratadine and pseudoephedrine sulfate) by Bayer. Approved for these symptoms due to hay fever, other upper respiratory allergies: sneezing itchy, watery eyes runny nose itching of the nose and 4 more indications. First approved in 1996.
Drug data last refreshed 15h ago · AI intelligence enriched 17h ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Claritin-D 24 Hour is an extended-release oral tablet combining loratadine (a non-sedating antihistamine) and pseudoephedrine sulfate (a nasal decongestant). It treats symptoms of hay fever and upper respiratory allergies including sneezing, itching, watery eyes, runny nose, and nasal congestion. The combination provides both allergy symptom relief and decongestant action for 24 hours.
LOE Approaching
With LOE approaching and moderate competitive pressure (30/100), this product faces declining market opportunity and likely contracting field teams and marketing support.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Worked on CLARITIN-D 24 HOUR at Bayer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.